iTeos Therapeutics has said it is evaluating with partner GlaxoSmithKline whether to conduct additional clinical trials of TIGIT drug EOS-448 following the failure of a key trial for Roche's rival ...

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the processors and graphics chips industry, including Qorvo (NASDAQ ...

The long-term thesis behind buying the stock is in place ... However, Kirby outlined that United was adjusting and would take more "leisure bookings instead of government bookings." ...

Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. Parnassus Investments, an investment management company, released the ...

Investing.com -- Hugo Boss (ETR:BOSSn) has projected its 2025 sales to remain at roughly the same level as the previous year, as the company braces for continued macroeconomic and geopolitical ...

Hugo Boss Results they did not convince investors, with the stock recording a decline of 4,36%, trading around 36,40 euros. Analysts' estimates were for sales of 4,26 billion euros in 2024 and 4 ...

The author and editors take ultimate responsibility for the content ... Image source: The Motley Fool. When the overall stock market drops, even high-quality companies with strong fundamentals ...

Signed by Governor Gavin Newsom in September 2022, California’s law required businesses to create reports addressing whether their online platforms could harm children, and take steps before ...

Previously the Walt Disney Co. issued its first stock through 6% cumulative preferred shares in 1940 where it was traded OTC (Over The Counter). Since IPO, Disney stock has been traded on the New ...

Pre-Market: 6:38:52 a.m. EDT Loading Chart for TTWO ...